The pharma giant has received the CDSCO nod to import sodium zirconium cyclosilicate powder for oral suspension (Lokelma) in ...

AstraZeneca Pharma India Ltd has received approval from India's drug regulator to import and sell sodium zirconium ...

Lokelma is used for the treatment of hyperkalaemia, a condition characterized by elevated potassium levels in the blood.

AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), ...

AstraZeneca Pharma India has received approval to import and sell sodium zirconium cyclosilicate (Lokelma) for treating hyperkalemia in adults in India. The drug is indicated for the treatment of ...

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...

NICE says that Lokelma can be used for non-dialysed patients with CKD or heart failure who have persistent hyperkalaemia with a potassium level of 6.0 mmol/litre or more that is preventing them ...

Investment analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for shares of AstraZeneca in a report issued on Thursday, February 27th. Zacks Research analyst R.

With this approval, durvalumab can now be used for treating patients with limited-stage small cell lung cancer (LS-SCLC) ...

Indian benchmark indices, Sensex and Nifty, reversed early gains and turned negative on Thursday, pressured by declines in ...

Since the Nifty peaked in late September 2024, the index is down over 15%. What is more disconcerting is that the markets have given negative returns in each of the last 5 months. This phenomenon ...